Search

everythinglearnresearchcommunity

for

Search:↓

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Tideglusib helps heal wounds in older skin.

Keratin 16 delays skin maturation and affects skin and hair development in mice.

Skin reactions from cancer treatments might predict how well the treatments work.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

Understanding EGFR roles could lead to new hair loss treatments.

Researchers found genes and genetic variants linked to sheep wool and skin wrinkles.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Increasing calcium sensing receptor speeds up skin and hair development in mice.

New medications could improve treatment for severe alopecia areata in Australia.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Certain cancer drugs can cause skin issues like rashes and itching.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Syntaxin 9 helps in transporting and signaling of the EGF receptor in skin and stomach cells.

YAP and TAZ proteins control skin cell growth and repair.